Hvivo, the Irish pharmaceutical services company founded by businessman Cathal Friel, has increased its sales and profit guidance for 2023 after reporting double-digit growth for the first six months of the year.
On Tuesday, the Dublin-headquartered company reported a 52 per cent increase in half year sales to £27.3 million on the back of new contract wins to run clinical trials and human challenge studies on behalf of large pharma and biotech companies.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: IrishTimes - 🏆 3. / 98 Consulte Mais informação »